Abstract:Abstract Objective: To investigate the value of carcinoembryonic antigen (CEA) change in predicting pathological tumor regression and outcome for locally advanced rectal cancer (LARC) patients received neoadjuvant therapy. Material and methods: LARC patients who received neoadjuvant therapy and radical tumor resection were retrospectively collected. The predictive value of baseline CEA, post-treatment CEA and post/pre-treatment CEA ratio for tumor regression grade (TRG), overall survival and diseases free survival were estimated by logistic regression or cox proportional hazard regression. Results: 700 LARC patients were enrolled in the study with 475 (67.9%) cases of male patients and median age of 56 (20-87). Of the all patients enrolled, multivariate analysis showed post-treatment CEA (OR=1.142, 95% CI: 1.073-1.215, P<0.001) was an independent predictor for TRG. 284 patients with elevated baseline CEA were analyzed. Among them, 168 patients (59.2%) have normalized CEA. Multivariate analysis showed post-treatment CEA (OR=1.068, 95% CI: 1.007-1.133, P=0.027), CEA ratio (OR=3.463, 95% CI: 1.269-9.446, P=0.015) were independent predictors for TRG(Table 1). Of the all patients enrolled, multivariate analysis showed low preoperative albumin level (HR=0.919, 95% CI: 0.886-0.952, P<0.001), tumor deposit (HR=3.226, 95% CI: 1.470-7.077, P=0.003), nerve infiltration (HR=3.602, 95% CI: 1.736-7.476, P=0.001), high post-treatment CEA (HR=1.029, 95% CI: 1.010-1.049, P=0.003) were independent unfavored predictors for overall survival of LARC patients. 700 patients were divided into 3 groups: A group with normal baseline CEA (n=416,59.4%); B group with normalized CEA (n=168,24.0%); C group with elevated baseline and post-treatment CEA (n=116,16.6%). The overall survival and disease free survival of group B were comparable to that of group A (P=0.588,0.053) and significantly better than that of group C (B vs. C: P=0.010, 0.003; A vs. C: P=0.007, <0.001). Conclusion: 1. Post-treatment CEA is an independent predictor for TRG of LARC patients and higher post-treatment CEA precdicted poor overall survival. 2. Post/pre-treatment CEA ratio is an independent predictor for TRG of LARC patients with elevated baseline CEA. Citation Format: Zerong Cai, Lingyu Huang, Ping Lan, Xiaojian Wu. Serum CEA change predicts tumor regression and prognosis in locally advanced rectal cancer [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3197.

CEA Clearance Pattern As a Predictor for Pathologic Complete Response after Neoadjuvant Chemoradiation for Rectal Cancer: Results of the FOWARC Trial.

175P CEA Clearance Pattern is a Strong Predictor of Pathologic Complete Response after Neoadjuvant Chemoradiation for Rectal Cancer: Validation of FOWARC Trial

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial

CEA Levels Predict Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer*

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA.

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

Assessing the predictive value of clinical factors to pathological complete response for locally advanced rectal cancer: An analysis of 124 patients

Abstract 3197: Serum CEA Change Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer

181P Initial CEA and CA19-9 Level Were Associated with Pathologic Outcome of Locally Advanced Rectal Cancer after Neoadjuvant Chemotherapy with or Without Radiotherapy: Results from a Prospective Study

Prediction of pathological complete response and prognosis in locally advanced rectal cancer

An Integrated Model of Pathological Complete Response and Postoperative CEA Predicts Survival and Benefit of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer

Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer

The Novel CFP Scoring System is a Reliable Marker in Predicting Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer

High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients

Predictive Value Of Apaf-1 And Cox-2 Expression In Pathologic Complete Response To Neoadjuvant Chemoradiotherapy For Patients With Locally Advanced Rectal Adenocarcinoma

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer

A Prognostic Analysis of Patients with Pathologic Complete Response after Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

[Predictive Value of Serum Carcinoembryonic Antigen Level in Efficacy and Prognosis for Patients with Rectal Cancer Following Preoperative Radiochemotherapy].

Circulating Tumor Cells: A Promising Marker of Predicting Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemo-Radiation Therapy